Assessing quick tests for action slowing in stroke and cognitive diseases
Official title: Diagnostic and Prognostic Value of New Quick Tests of Action Slowing in Stroke and in Cognitive Neurodegenerative Disease
Run by Centre Hospitalier Universitaire, Amiens · NCT05785156 · Data updated 2026-11-12
This study is testing new quick tests to see if they can help doctors understand how action slowing in stroke and cognitive disease patients can predict their recovery and diagnose conditions like Alzheimer's earlier.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years to 85 Years |
| Sex | All |
| Enrollment | 129 (estimated) |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Amiens) |
| Status | Recruiting |
| Started | July 16, 2021 |
| Main results expected | July 16, 2027 |
| Study ends | July 16, 2027 |
| Registry record updated | May 13, 2026 |
| Trial ID | NCT05785156 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are French-speaking patients aged 40 to 85 with mild to major cognitive disorders related to Alzheimer's disease or other specified neurodegenerative conditions.
✕Probably not a fit
Patients with a history of severe brain conditions, previous dementia diagnoses, or significant psychiatric disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the diagnostic and prognostic value of new quick tests that measure action slowing in patients with acute stroke and various cognitive neurodegenerative disorders, including Alzheimer's disease and related conditions. The study will investigate how action slowing can predict functional outcomes in stroke patients and its relevance in diagnosing early stages of neurodegenerative diseases. By analyzing the anatomical determinants of action slowing, the research seeks to enhance understanding of these conditions and improve diagnostic methods.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic tools and prognostic assessments for patients with stroke and cognitive neurodegenerative diseases.
How similar studies have gone: While there is ongoing research into action slowing in brain diseases, this specific approach using new quick tests is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients between 40 and 85 years old, * French native language, * Social Security affiliation. * University Memory Clinic for: Mild severity disorder (MMSE\> 19) or major severity disorder related to AD : Albert 2011 criteria ; McKhann 2011 * to MCL according to McKeith criteria * to FTLD according to Rascovsky 2011 criteria * BBD according to Armstrong's criteria * related to PSP according to Höglinger criteria Exclusion Criteria: * Mental retardation or guardianship * Previously diagnosed dementia * Other current or past brain condition * severe head trauma * epilepsy prior to stroke still requiring previous treatment * Parkinson disease, multiple sclerosis... * brain tumor or brain radiation therapy * Current or past schizophrenia or psychosis * Active or past psychiatric disorders requiring a stay\> 2 days in a specialized environment * Contra indication to MRI * Comorbidity with life expectancy \<1 year * Comorbidity affecting cognition in particular: * Alcohol (\> 3 glasses / day) or history of alcohol withdrawal syndrome * opiate or cocaine addiction or opiate withdrawal syndrome * renal failure (dialysis or creatinine clearance \<30) * hepatic failure (spontaneous INR\> 1.5 or PT \<60%) * respiratory failure requiring oxygen therapy * heart failure (orthopnea\> 2 pillows) * persistent vigilance disturbances (NIHSS1a score ≤1) * cancer with paraneoplastic syndrome * treatment with gold salts, D Penicillamine or other treatment with cognitive effect * Patient under guardianship or curators or private under public law * Pregnant and / or lactating wom
Where it's running
-
CHU Amiens
Amiens, France Recruiting
Study contacts
- Study coordinator: Martine ROUSSEL, PhD
- Email: roussel.martine@chu-amiens.fr
- Phone: 0322667813
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Motor learning with physical activity and advanced devices in healthy people and movement disorders
This study tests whether combining traditional physical activity with advanced devices and immersive therapy helps improve motor skills and functional recovery in healthy individuals and people with movement disorders.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
Longitudinal study on brain health and risk factors for neurological diseases
This study is trying to understand how different health factors affect brain health over time in people who are at risk for conditions like stroke and dementia.
-
Treatment for neurologic disorders using stem cells
This study is testing whether using stem cells from patients' own bone marrow can help improve brain and nerve function in people with serious neurologic disorders that don't respond well to regular treatments.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.